American Journal of Cardiology
Volume 91, Issue 6 , Pages 744-746 , 15 March 2003

Predictors of aortic and coronary artery calcium on a screening electron beam tomographic scan

  • Paolo Raggi, MD

      Affiliations

    • Tulane University School of Medicine, New Orleans, Lousiana, USA
    • Corresponding Author InformationDr. Raggi’s address is: Tulane University School of Medicine, 1430 Tulane Avenue, SL-48, New Orleans, Lousiana 70112, USA.
    • ,
  • Bruce Cooil, PhD

      Affiliations

    • Owen School of Management, Vanderbilt University, Nashville, Tennessee, USA
    • ,
  • Azam Hadi, MD

      Affiliations

    • Tulane University School of Medicine, New Orleans, Lousiana, USA
    • ,
  • Gerald Friede, MR

      Affiliations

    • Heartscan of San Diego, La Jolla, California, USA

Received 4 September 2002 ,Revised 14 November 2002 ,Accepted 14 November 2002.

References 

  1. Greenland P, Smith SC, Grundy SM. Improving coronary heart disease risk assessment in asymptomatic people. Role of traditional risk factors and noninvasive cardiovascular tests. Circulation. 2001;104:1863–1867
  2. Friedewald W, Levy R, Fredrickson D. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–502
  3. Blanco-Vaca F, Arcelus R, Gonzalez-Sastre F, Ordonez-Llanos J, Queralto-Compano JM. Comparison of the Abbott Imx and high performance liquid chromatography method for measuring total plasma homocysteine. Clin Chem Lab Med. 2000;38:327–329
  4. Corsetti JP, Sterry JA, Sparks CT, Weintraub M. Effect of weight loss on serum lipoprotein (a) concentration in an obese population. Clin Chem. 1991;37:1191–1195
  5. Callister TQ, Cooil B, Raya S, Lippolis NJ, Russo DJ, Raggi P. Coronary artery disease (improved reproducibility of calcium scoring with an electron beam-CT volumetric method). Radiology. 1998;208:807–814
  6. Schwarz G. Estimating the dimension of a model. Ann Statistics. 1978;6:461–464
  7. Woodroofe M. On model selection and the arc sine laws. Ann Statistics. 1982;10:1182–1194
  8. Superko HR, Hecht HS. Metabolic disorders contribute to subclinical coronary atherosclerosis in patients with coronary calcification. Am J Cardiol. 2001;88:260–264
  9. Nishino M, Malloy MJ, Naya-Vigne J, Russell J, Kane JP, Redberg RF. Lack of association of lipoprotein (a) levels and coronary calcium deposits in asymptomatic postmenopausal women. J Am Coll Cardiol. 2000;35:314–320
  10. Darling GM, Johns JA, McCloud PI, Davis SR. Estrogen and progestin compared with simvastatin for hypercholesterolemia in postmenopausal women. N Engl J Med 1997;337:595–601
  11. Haines C, Chung T, Chang A, Masarei J, Tomlinson B, Wong E. Effect of oral estradiol on Lp(a) and other lipoproteins in postmenopausal women. A randomized, double-blind, placebo-controlled, crossover study. Arch Intern Med. 1996;156:866–872
  12. Shlipak MG, Simon JA, Vittinghoff E, Lin F, Barrett-Connor E, Knopp RH, et al. Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause. JAMA. 2000;283:1845–1852
  13. Taylor AJ, Feuerstein I, Wong H, Barko W, Brazaitis M, O’Malley PG. Do conventional risk factors predict subclinical coronary artery disease? Results from the Prospective Army Coronary Calcium Project. Am Heart J. 2001;141:463–468
  14. Sternby NH, Vanecek R, Vihert A, Kagan A, Uemura K. Correlation of type and extent of atherosclerosis in aorta and coronary arteries obtained at autopsy. Bull Wld Hlth Org. 1965;33:741–760
  15. Oei HH, Vliegenthart R, Hak AE, Iglesias del Sol A, Hofman A, Oudkerk M, et al. The association between coronary calcification assessed by electron beam computed tomography and measures of extracoronary atherosclerosis (the Rotterdam Coronary Calcification Study). J Am Coll Cardiol. 2002;39:1745–1751

PII: S0002-9149(02)03421-5

doi: 10.1016/S0002-9149(02)03421-5

American Journal of Cardiology
Volume 91, Issue 6 , Pages 744-746 , 15 March 2003

Article Tools